These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16116478)

  • 41. Functional characterization of E- and P-cadherin in invasive breast cancer cells.
    Sarrió D; Palacios J; Hergueta-Redondo M; Gómez-López G; Cano A; Moreno-Bueno G
    BMC Cancer; 2009 Mar; 9():74. PubMed ID: 19257890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis.
    Liu YN; Liu Y; Lee HJ; Hsu YH; Chen JH
    Mol Cell Biol; 2008 Dec; 28(23):7096-108. PubMed ID: 18794357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression.
    Graff JR; Gabrielson E; Fujii H; Baylin SB; Herman JG
    J Biol Chem; 2000 Jan; 275(4):2727-32. PubMed ID: 10644736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
    Brett A; Pandey S; Fraizer G
    Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression.
    Yori JL; Johnson E; Zhou G; Jain MK; Keri RA
    J Biol Chem; 2010 May; 285(22):16854-63. PubMed ID: 20356845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles for E-cadherin cell surface regulation in cancer.
    Petrova YI; Schecterson L; Gumbiner BM
    Mol Biol Cell; 2016 Nov; 27(21):3233-3244. PubMed ID: 27582386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation.
    Yang JY; Zong CS; Xia W; Wei Y; Ali-Seyed M; Li Z; Broglio K; Berry DA; Hung MC
    Mol Cell Biol; 2006 Oct; 26(19):7269-82. PubMed ID: 16980628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NRBE3 promotes metastasis of breast cancer by down-regulating E-cadherin expression.
    Zheng T; Lu M; Wang T; Zhang C; Du X
    Biochim Biophys Acta Mol Cell Res; 2018 Dec; 1865(12):1869-1877. PubMed ID: 30262434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of mechanisms for decrease or loss of E-cadherin expression in human melanoma cells].
    Tsutsumida A
    Hokkaido Igaku Zasshi; 2002 Sep; 77(5):439-47. PubMed ID: 12404759
    [No Abstract]   [Full Text] [Related]  

  • 50. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.
    Poser I; Domínguez D; de Herreros AG; Varnai A; Buettner R; Bosserhoff AK
    J Biol Chem; 2001 Jul; 276(27):24661-6. PubMed ID: 11323412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.
    DesRochers TM; Shamis Y; Alt-Holland A; Kudo Y; Takata T; Wang G; Jackson-Grusby L; Garlick JA
    Epigenetics; 2012 Jan; 7(1):34-46. PubMed ID: 22207358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased α-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.
    Kovac B; Mäkelä TP; Vallenius T
    PLoS One; 2018; 13(5):e0196986. PubMed ID: 29742177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer.
    Fearon ER
    Cancer Cell; 2003 Apr; 3(4):307-10. PubMed ID: 12726856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of Cadherin-17 Promotes Metastasis in a Highly Bone Marrow Metastatic Murine Breast Cancer Model.
    Okada T; Kurabayashi A; Akimitsu N; Furihata M
    Biomed Res Int; 2017; 2017():8494286. PubMed ID: 28197418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer.
    Deng Y; Deng H; Liu J; Han G; Malkoski S; Liu B; Zhao R; Wang XJ; Zhang Q
    Mol Carcinog; 2012 Jun; 51(6):500-7. PubMed ID: 21681822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HOXD3-overexpression increases integrin alpha v beta 3 expression and deprives E-cadherin while it enhances cell motility in A549 cells.
    Ohta H; Hamada J; Tada M; Aoyama T; Furuuchi K; Takahashi Y; Totsuka Y; Moriuchi T
    Clin Exp Metastasis; 2006; 23(7-8):381-90. PubMed ID: 17187229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mechanism of ovarian cancer metastasis--changes in E-cadherin expression].
    Horiuchi A; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():463-6. PubMed ID: 15535288
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance.
    Chao Y; Wu Q; Shepard C; Wells A
    Clin Exp Metastasis; 2012 Jan; 29(1):39-50. PubMed ID: 21964676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis.
    Li Z; Yin S; Zhang L; Liu W; Chen B
    Oncotarget; 2017 Mar; 8(10):16445-16455. PubMed ID: 28147315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms controlling E-cadherin expression in breast cancer.
    Baranwal S; Alahari SK
    Biochem Biophys Res Commun; 2009 Jun; 384(1):6-11. PubMed ID: 19379710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.